While our previous paper identified IL-7 as a myokine biomarker for PAD, the current study is innovative in that we discovered a novel PAD biomarker, ST2, which has a unique biological relationship with PAD through its involvement in various mechanistic pathways of atherosclerosis, thrombosis, and plaque vulnerability. Here, IL1RL1 is linked to peripheral arterial disease.